Personalized Medicine Market Opportunities

January 2013 | 178 pages | ID: PD61B89FFC4EN
Red Mountain Insights

Abstracts

This report is a comprehensive analysis of the Personalized Medicines market. We explore the benefits and disadvantages of personal medicines, the role of pharmacogenomics, role of diagnostic tools, emergence of linked diagnostics and therapeutics, the efficacy of treatment with personalized medicines and many other factors.

We also include an analysis of whether the emergence of personalized medicines means an end of the era of blockbuster drugs. We also examine the benefits for businesses and partnership/alliance models in the market, followed by an analysis of the essentials of personalized medicine practice.

Genetics has changed the face of the pharmaceutical industry today. With advances in the field of genetics, it is now possible to customize even your medicines according to your genetic constitution. The emergence of personalized medicines has taken the pharmaceutical industry by storm.

With genetics making it possible to personalize your medicines, it has now become possible to tailor medicines to cure diseases such as cancer, sinusitis and scientists are looking at options for curing AIDS as well with personalized medicines. Often described as the right treatment for the right person at the right time, personalized medicines however face many challenges before they become widely available, the biggest challenge being regulatory hurdles and cost.

The applications of personalized medicines in predictive medicine, treatment optimization, cancer, pharmacogenetics and pharmacometabolomics as well as other met and unmet therapy areas are also examined in this report. An analysis of the regulatory framework that is critical to the success of personalized medicines is included.

The economic impact of personalized medicines and the role of venture capital in this market are also examined. Since technology obviously plays a major role in the development of personalized medicines, we analyze the various technology platforms as well as the technological requirements for the personalized medicines market.

Challenges facing the industry as well as a look at the key markets where personalized medicines are being used is included, followed by an analysis of the personalized medicine applications currently on the market and the major industry players.

Contents

What is Personalized Medicine?
Introduction
Advantages & Disadvantages of Personal Medicine
Role of Pharmacogenomics
Role of Diagnostic Tools
Molecular Diagnostics
Personal Genomes and Genetic Profiles
Emergence of Linked Diagnostics and Therapeutics
Clinical Domains
Personalized Medicine & Medical Technology Innovation Pathway
Increasing Treatment Efficacy with Personalized Medicines
Capabilities System of Personalized Medicine (PMx)
End of Blockbuster Drugs?
Impact of Personalized Medicine on Healthcare
Partnership & Alliance Models in Personalized Medicine
Benefits for Businesses
Essentials of Personalized Medicine Practice
Applications of Personalized Medicine
Predictive Medicine
Treatment Optimization
Cancer
Overview
Ovarian Cancer
Cervical Cancer
Pharmacogenetics & Pharmacometabolomics
Chronic Sinusitis
Met & Unmet Therapy Areas
Regulatory Framework
Federal Agencies Involved in Personalized Medicine
Role of the US FDA
Role of CMS/CLIA
FDA & CLIA Regulation
Critical Path Initiative
Function & Content of Agencies Involved in Personalized Medicine
Economics of Personalized Medicine
Economic Impact of Personalized Medicines
Role of Venture Capital in Personalized Medicine
Technology Platforms
Expression Profiling - RNA & Pharmacogenomics
Proteins & Pharmacoproteomics
DNA Sequence Profiling - Pharmacogenetic & SNP Analysis
High-throughput Sequencing
Role of Amplification Technologies
Technological Requirements
Overview
Genome Sequencing
Single Nucleotide Polymorphisms
DNA Structural Variation
Expression Microarrays
Role of Biospecimen Banks
Challenges Facing Personalized Medicine
Discrimination Concerns
Issues for Insurers
Technological Challenges
Intellectual Property Protection
Public/Private Investment
Development of Key Translational Tools
Key Market Analysis
Europe
Canada
United States
Personalized Medicine Applications Currently on the Market
AlloMap® Test
AmpliChip® CYP450 Test
Antiretroviral Drug Resistance Tests
HER2/neu Tests
HLA B*5701 Test
Invader® UGT1A1 Assay
Oncotype DX®
TPMT Assays
Trofile Assay
Warfarin Metabolism Tests
Major Players
20/20 GENESYSTEMS
A&G Pharmaceutical, Inc
ACGT, Inc.
ACM Medical Laboratory, Inc.
Advanced Cell Diagnostics, Inc.
Ambry Genetics Corporation
ApoCell, Inc.
Arcxis Biotechnologies, Inc.
AssureRx
Aushon BiosyStems, Inc.
AutoGenomics Inc.
BioNanomatrix, Inc.
Cellular Dynamics International, Inc.
Cira Discovery Sciences, Inc.
CombiMatrix Corporation
Cypress Bioscience, Inc
Gene Express Inc
Genetics Squared, Inc.
Genomas, Inc.
Genomica Corp.
Gentris Clinical Genetics, Inc.
Golden Helix, Inc.
Health Discovery Corp.
HistoRx
ICON Laboratories, Inc.
Illumina Inc
Intrinsic LifeSciences LLC
Iris Biotechnologies Inc
LineaGen Research Corporation
Lipomics Technologies, Inc.
Medical Diagnostic Laboratories
Myriad Genetics Inc.
Nanosphere, Inc.
NanoString Technologies
Proventys, Inc.
QuantRX Biomedical Corporation
Rheonix, Inc.
RxGen PrimaTox, Inc.
Sequenom Inc.
SeqWright Incorporated
Serametrix Corporation
Smart Personalized Medicine, LLC
Tethys Bioscience
Waban Software, Inc.
Future of Personalized Medicines
Glossary